Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing date is May 21, 2025, covering a share repurchase executed on May 20, 2025. The transaction was conducted through Citigroup Global Markets Limited as part of an existing buyback programme established via a non-discretionary agreement on February 24, 2025.
Key Financial Metrics
The filing details a specific share repurchase event rather than comprehensive financial statements. Key metrics for the transaction are as follows:
- Shares Purchased: 570,340 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,402.50p; highest price paid was 1,426.50p.
- Average Price: Volume-weighted average price (VWAP) was 1,416.29p.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON).
- Treasury Shares: Following this purchase, GSK holds 213,380,333 ordinary shares in treasury.
- Shares in Issue: 4,101,878,526 ordinary shares (excluding treasury shares).
- Voting Rights: Total voting rights are 4,101,878,526.
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
Since the commencement of the buyback programme on February 24, 2025, the Company has purchased an aggregate of 44,310,030 ordinary shares. The May 20, 2025 transaction represents a continuation of this programme. No other material changes to the company's financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains a standard cautionary statement regarding forward-looking statements. GSK notes that projections are subject to risks and uncertainties that may cause actual results to differ materially. Investors are directed to the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024 and the Q1 Results for 2025 for a detailed description of these risks. No new guidance or management commentary regarding future financial performance is provided in this document.
Investor Verification Checklist
- Verify the total number of treasury shares held (213,380,333) against the latest Form 20-F or quarterly reports.
- Confirm the remaining authorization under the buyback programme initiated on February 24, 2025.
- Review the Q1 2025 results and the 2024 Form 20-F for context on the company's overall liquidity and capital allocation strategy.
- Check the current share price relative to the VWAP of 1,416.29p paid on May 20, 2025.